Barco Demetra® is a revolutionary skin imaging platform co-developed with leading dermatologists. Demetra is a platform that will evolve over time. We are continuously working on new groundbreaking capabilities, including deep learning algorithms, all developed to improve the quality of skin diagnoses.

When a large amount of digital skin images are available, it becomes possible to develop a deep learning algorithm that can assist with detection and diagnosis of skin cancer. AI can automate detection of dermoscopic details, for example. And computer-aided ABCD scoring (Asymmetry, Border, Colour, Diameter) can help doctors identify whether a skin lesion is benign or malignant.

What’s more, in the future, AI can provide medical advice to general practitioners when performing a first screening. The algorithm can provide risk scores and advise general practitioners to refer the patient to a dermatologist or do the follow-up themselves. It means that dermatologists can give priority to high-risk patients.

Research on digital skin parameter maps looks promising. These maps give an exceptionally clear view on skin structures, blood vessels and tissue composition.
Research on digital skin parameter maps looks promising. These maps give an exceptionally clear view on skin structures, blood vessels and tissue composition.

This can help put an end to patient waiting times of three months or longer. When you know that health outcomes depend on early detection, this can potentially save lives.

Business Value

Demetra is a new value proposition in a market which is new to Barco, but has been developed based on Barco’s technological expertise. The medical market is very demanding and critical, that’s exactly why product scope and positioning are the key to success.

Implementation Plan

Barco received the green light from the European authorities last year for Demetra. The dermatology platform has completed a pilot run in Belgium and Germany and will be made available in more countries during 2020, including the USA following FDA clearance granted in December 2019.

Imagine a smarter way of doing skin examinations. That’s what Demetra is all about. Smartly enhancing your workflow. Taking dermoscopic, close-up and overview images. Providing intelligent and augmented insights. While remaining uniquely affordable, accessible and future-proof. Demetra is ingeniously designed to expand your expertise.
Company
Skills
Used technologies
Complexity
Hard
Effort Needed
2+ years
ROI
TBA
Customer
external partners and in-house
Industry
Healthcare
Partner
In The Pocket, Cloudar, Verhaert
Application Type
development
Tech Stack
Frontend: React, GraphQL
Backend: AWS
Device: Android, Kotlin
AI: Python, Tensorflow
Learning Path
Others
Github
X
X